Granules India Limited (GRANULES)

575.65

INR
+32.60(+6.00%)
As of December 6, 2024 10:00:00 AM

Granules India Limited Share Price Information

24 hour Low and High

Low: 540.8
High: 574.35

All time High

10296.74

Price Change 1h

+₹32.60 +6.00%

Price Change 1d

+₹32.60 +6.00%

Price Change 1w

+₹41.75 +7.82%

Granules India Limited Market Information

Exchange

NSE

Market Cap

13446.63 Cr

About Granules India Limited Share

Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationlly. The company's APIs in various therapeutic categories include anti-retrovirals, anti-hypertensives, anti-histamines, anti-infectives, analgesics, anti-coagulants, anti-fibriotics, and platelet inhibitors. It also offers tablets, caplets, and press-fit capsules in bulk, blister packs, and bottles; high potent products; and other products for oncology. Granules India Limited was founded in 1984 and is based in Hyderabad, India.

Sector

Healthcare

Drug Manufacturers - Specialty & Generic

Employees

about

4057

CEO

Dr. Kandiraju Venkata Sita Ram Rao B.Tech, M.E., Ph.D.

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • Granules India share tanks 10% after USFDA's 'OAI' tag for Gagillapur Unit
  • Granules India shares dive 11% in late deals today; here's why
  • Granules India's Stock Sees -6.7% Decline, Underperforms Market in One Day
  • Granules India's Gagillapur facility warrants regulatory action, the USFDA says
  • Granules India faces US FDA inspection challenges at Gagillapur facility

FAQs

Granules India Limited (GRANULES)

575.65

INR
+32.60(+6.00%)
As of December 6, 2024 10:00:00 AM

Granules India Limited Share Price Information

24 hour Low and High

Low: 540.8
High: 574.35

All time High

10296.74

Price Change 1h

+₹32.60 +6.00%

Price Change 1d

+₹32.60 +6.00%

Price Change 1w

+₹41.75 +7.82%

Granules India Limited Market Information

Exchange

NSE

Market Cap

13446.63 Cr

About Granules India Limited Share

Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationlly. The company's APIs in various therapeutic categories include anti-retrovirals, anti-hypertensives, anti-histamines, anti-infectives, analgesics, anti-coagulants, anti-fibriotics, and platelet inhibitors. It also offers tablets, caplets, and press-fit capsules in bulk, blister packs, and bottles; high potent products; and other products for oncology. Granules India Limited was founded in 1984 and is based in Hyderabad, India.

Sector

Healthcare

Drug Manufacturers - Specialty & Generic

Employees

about

4057

CEO

Dr. Kandiraju Venkata Sita Ram Rao B.Tech, M.E., Ph.D.

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • Granules India share tanks 10% after USFDA's 'OAI' tag for Gagillapur Unit
  • Granules India shares dive 11% in late deals today; here's why
  • Granules India's Stock Sees -6.7% Decline, Underperforms Market in One Day
  • Granules India's Gagillapur facility warrants regulatory action, the USFDA says
  • Granules India faces US FDA inspection challenges at Gagillapur facility

FAQs